{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:06:45Z","timestamp":1784286405415,"version":"3.55.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":4297,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.ymthe.2004.08.027","type":"journal-article","created":{"date-parts":[[2004,12,16]],"date-time":"2004-12-16T13:07:31Z","timestamp":1103202451000},"page":"35-47","source":"Crossref","is-referenced-by-count":69,"title":["Liver-directed neonatal gene therapy prevents cardiac, bone, ear, and eye disease in mucopolysaccharidosis I mice"],"prefix":"10.1016","volume":"11","author":[{"given":"Yuli","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingfei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne K.","family":"Hennig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabel","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin S.","family":"Herati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Mosinger Ogilvie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Rong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Parker Ponder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2004.08.027_bib1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ymthe.2004.08.027_bib2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1023\/B:BOLI.0000031101.12838.c6","article-title":"Enzyme replacement and enhancement therapies for lysosomal diseases","volume":"27","author":"Desnick","year":"2004","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymthe.2004.08.027_bib3","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/sj.gt.3302092","article-title":"Gene therapy progress and prospects: gene therapy of lysosomal storage disorders","volume":"10","author":"Cheng","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2004.08.027_bib4","series-title":"Metabolic and Molecular Basis of Inherited Disease","first-page":"3421","article-title":"The mucopolysaccharidoses","author":"Neufeld","year":"2001"},{"key":"10.1016\/j.ymthe.2004.08.027_bib5","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1006\/mthe.2002.0809","article-title":"Evaluation of pathological manifestations of disease in mucopolysaccharidosis VII mice after neonatal hepatic gene therapy","volume":"6","author":"Xu","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2004.08.027_bib6","doi-asserted-by":"crossref","first-page":"13102","DOI":"10.1073\/pnas.192353499","article-title":"et al. Therapeutic neonatal hepatic gene therapy in mucopolysaccharidosis VII dogs","volume":"99","author":"Ponder","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2004.08.027_bib7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ymgme.2004.01.015","article-title":"et al. Neonatal retroviral vector-mediated hepatic gene therapy reduces bone, joint, and cartilage disease in mucopolysaccharidosis VII mice and dogs","volume":"82","author":"Mango","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2004.08.027_bib8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1006\/mthe.2002.0527","article-title":"et al. Transduction of hepatocytes after neonatal delivery of a Moloney murine leukemia virus-based retroviral vector results in long-term expression of \u03b2-glucuronidase in mucopolysaccharidosis VII dogs","volume":"5","author":"Xu","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2004.08.027_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ymthe.2004.04.010","article-title":"et al. In vivo transduction of hematopoietic stem cells after neonatal intravenous injection of an amphotropic retroviral vector in mice","volume":"10","author":"Xu","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2004.08.027_bib10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10024001-0079-1","article-title":"Murine mucopolysaccharidosis VII: impact of therapies on the phenotype, clinical course, and pathology in a model of a lysosomal storage disease","volume":"4","author":"Vogler","year":"2001","journal-title":"Pediatr. Dev. Pathol."},{"key":"10.1016\/j.ymthe.2004.08.027_bib11","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/sj.gt.3301420","article-title":"Prevention of systemic clinical disease in MPS VII mice following AAV-mediated neonatal gene transfer","volume":"8","author":"Daly","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2004.08.027_bib12","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1006\/exer.2000.0897","article-title":"Retinal function is improved in a murine model of a lysosomal storage disease following bone marrow transplantation","volume":"71","author":"Ohlemiller","year":"2000","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ymthe.2004.08.027_bib13","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ymthe.2004.03.018","article-title":"AAV-mediated intravitreal gene therapy reduces lysosomal storage in the retinal pigmented epithelium and improves retinal function in adult MPS VII mice","volume":"10","author":"Hennig","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2004.08.027_bib14","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1161\/01.CIR.0000138747.82487.4B","article-title":"et al. Gene therapy ameliorates cardiovascular disease in dogs with mucopolysaccharidosis VII","volume":"110","author":"Sleeper","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ymthe.2004.08.027_bib15","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF00206770","article-title":"An update on the frequency of mucopolysaccharide syndromes in British Columbia","volume":"85","author":"Lowry","year":"1990","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymthe.2004.08.027_bib16","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/hmg\/6.4.503","article-title":"et al. Murine mucopolysaccharidosis type I: targeted disruption of the murine alpha-l-iduronidase gene","volume":"6","author":"Clarke","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2004.08.027_bib17","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1073\/pnas.252784899","article-title":"Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB","volume":"100","author":"Ohmi","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2004.08.027_bib18","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1203\/00006450-197911000-00018","article-title":"Alpha-l-iduronidase deficiency in a cat: a model of mucopolysaccharidosis I","volume":"13","author":"Haskins","year":"1979","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymthe.2004.08.027_bib19","first-page":"244","article-title":"Canine alpha-l-iduronidase deficiency: a model of mucopolysaccharidosis I","volume":"109","author":"Shull","year":"1982","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2004.08.027_bib20","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.1016\/S0021-9258(19)50465-3","article-title":"et al. Cloning and characterization of cDNA encoding canine alpha-l-iduronidase: mRNA deficiency in mucopolysaccharidosis I dog","volume":"267","author":"Stoltzfus","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2004.08.027_bib21","first-page":"787","article-title":"Immunoquantification and enzyme kinetics of alpha-l-iduronidase in cultured fibroblasts from normal controls and mucopolysaccharidosis type I patients","volume":"50","author":"Ashton","year":"1992","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2004.08.027_bib22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0925-4439(98)00046-5","article-title":"Genotype\u2013phenotype correlations in mucopolysaccharidosis type I using enzyme kinetics, immunoquantification and in vitro turnover studies","volume":"1407","author":"Bunge","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymthe.2004.08.027_bib23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1096-7192(03)00116-1","article-title":"Treatment of the mouse model of mucopolysaccharidosis I with retrovirally transduced bone marrow","volume":"79","author":"Zheng","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2004.08.027_bib24","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ymthe.2004.03.011","article-title":"et al. Correction of metabolic, craniofacial, and neurologic abnormalities in MPS I mice treated at birth with adeno-associated virus vector transducing the human alpha-l-iduronidase gene","volume":"9","author":"Hartung","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2004.08.027_bib25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0378-5955(02)00341-6","article-title":"Inner ear pathology in the mucopolysaccharidosis VII mouse","volume":"169","author":"Ohlemiller","year":"2002","journal-title":"Hear. Res."},{"key":"10.1016\/j.ymthe.2004.08.027_bib26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1182\/blood-2003-06-2181","article-title":"Neonatal gene transfer with a retroviral vector results in tolerance to human factor IX in mice and dogs","volume":"103","author":"Zhang","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2004.08.027_bib27","doi-asserted-by":"crossref","first-page":"12937","DOI":"10.1073\/pnas.91.26.12937","article-title":"Enzyme replacement in a canine model of Hurler syndrome","volume":"91","author":"Shull","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2004.08.027_bib28","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1056\/NEJM200101183440304","article-title":"et al. Enzyme-replacement therapy in mucopolysaccharidosis I","volume":"344","author":"Kakkis","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2004.08.027_bib29","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1006\/mgme.2000.3140","article-title":"et al. Enzyme replacement therapy in feline mucopolysaccharidosis I","volume":"72","author":"Kakkis","year":"2001","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymthe.2004.08.027_bib30","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1006\/bmme.1996.0044","article-title":"et al. Long-term and high-dose trials of enzyme replacement therapy in the canine model of mucopolysaccharidosis I","volume":"58","author":"Kakkis","year":"1996","journal-title":"Biochem. Mol. Med."},{"key":"10.1016\/j.ymthe.2004.08.027_bib31","doi-asserted-by":"crossref","first-page":"22758","DOI":"10.1074\/jbc.272.36.22758","article-title":"Carbohydrate structures of recombinant human alpha-l-iduronidase secreted by Chinese hamster ovary cells","volume":"272","author":"Zhao","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2004.08.027_bib32","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1006\/geno.1994.1621","article-title":"et al. Murine alpha-l-iduronidase: cDNA isolation and expression","volume":"24","author":"Clarke","year":"1994","journal-title":"Genomics"},{"key":"10.1016\/j.ymthe.2004.08.027_bib33","first-page":"A528","article-title":"Cardiac malfunction in the mouse model of Hurler syndrome (MPS I)","volume":"17","author":"Zheng","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2004.08.027_bib34","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0002-9149(03)00909-3","article-title":"et al. Usefulness of bone marrow transplantation in the Hurler syndrome","volume":"92","author":"Braunlin","year":"2003","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ymthe.2004.08.027_bib35","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.2460\/ajvr.1990.51.12.2054","article-title":"Cardiovascular changes after bone marrow transplantation in dogs with mucopolysaccharidosis I","volume":"51","author":"Gompf","year":"1990","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.ymthe.2004.08.027_bib36","first-page":"677","article-title":"Long-term effects of bone marrow transplantation in dogs with mucopolysaccharidosis I","volume":"134","author":"Breider","year":"1989","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2004.08.027_bib37","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1302\/0301-620X.76B6.7983131","article-title":"Bone-marrow transplantation in Hurler's syndrome: effect on skeletal development","volume":"76","author":"Field","year":"1994","journal-title":"J. Bone Joint Surg. Br."},{"key":"10.1016\/j.ymthe.2004.08.027_bib38","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0022-3476(98)70201-X","article-title":"Follow-up of nine patients with Hurler syndrome after bone marrow transplantation","volume":"133","author":"Guffon","year":"1998","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymthe.2004.08.027_bib39","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0161-6420(86)33537-1","article-title":"Electroretinographic findings in the mucopolysaccharidoses","volume":"93","author":"Caruso","year":"1986","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2004.08.027_bib40","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0161-6420(98)96014-6","article-title":"Ocular abnormalities in the mucopolysaccharidoses after bone marrow transplantation: longer follow-up","volume":"105","author":"Gullingsrud","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymthe.2004.08.027_bib41","first-page":"1802","article-title":"Corneal opacity in canine MPS I: changes after bone marrow transplantation","volume":"30","author":"Constantopoulos","year":"1989","journal-title":"Invest. Ophthalmol. Visual Sci."},{"key":"10.1016\/j.ymthe.2004.08.027_bib42","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1651-2227.1995.tb13640.x","article-title":"The presenting features of mucopolysaccharidosis type IH (Hurler syndrome)","volume":"84","author":"Cleary","year":"1995","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymthe.2004.08.027_bib43","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1007\/s00431-003-1348-y","article-title":"Lysosomal storage disorders: emerging therapeutic options require early diagnosis","volume":"162","author":"Meikle","year":"2003","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymthe.2004.08.027_bib44","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1089\/hum.1996.7.13-1595","article-title":"Myoblast gene therapy in canine mucopolysaccharidosis. I. Abrogation by an immune response to alpha-l-iduronidase","volume":"7","author":"Shull","year":"1996","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2004.08.027_bib45","first-page":"1895","article-title":"et al. Genetically corrected autologous stem cells engraft, but host immune responses limit their utility in canine alpha-l-iduronidase deficiency","volume":"93","author":"Lutzko","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2004.08.027_bib46","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1073\/pnas.0305480101","article-title":"et al. Successful induction of immune tolerance to enzyme replacement therapy in canine mucopolysaccharidosis I","volume":"101","author":"Kakkis","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2004.08.027_bib47","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.1088547","article-title":"et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1","volume":"302","author":"Hacein-Bey-Abina","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2004.08.027_bib48","first-page":"182","article-title":"The cell populations of the human liver","volume":"57","author":"Gates","year":"1961","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.ymthe.2004.08.027_bib49","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/hep.510300602","article-title":"et al. Lipopolysaccharide potentiates the effect of hepatocyte growth factor on hepatocyte replication in rats by augmenting AP-1 activity","volume":"30","author":"Gao","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.ymthe.2004.08.027_bib50","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1182\/blood-2002-10-3050","article-title":"et al. Neonatal or hepatocyte growth factor-potentiated adult gene therapy with a retroviral vector results in therapeutic levels of canine factor IX for hemophilia B","volume":"101","author":"Xu","year":"2003","journal-title":"Blood"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001604014248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001604014248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T11:55:16Z","timestamp":1734782116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001604014248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S1525001604014248"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2004.08.027","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}